It is a pharma private limited company based in Siliguri, West Bengal, India, established in 2012.
2012 | Siliguri, West Bengal, India | ActiveKanchanjanga Medipharma Private Limited, a active private limited company, was established on 02 August 2012 in Siliguri, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233WB2012PTC184337. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.01 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 55 professional, Its leadership includes Dilip Kumar Saha (Director), Sujata Bhowal (Director), Pradip Kumar Paul (Director). Past directors included Milan Bhowal. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Majumder Medi Trade, Kuchery Rd Opp. Siliguri Hospital,, Siliguri, West Bengal, 734001.
U24233WB2012PTC184337
184337
02 August 2012
₹1.01 Cr
₹1.00 Cr
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Kanchanjanga Medipharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dilip Kumar Saha | Director | 25 Jun 2013 | Current |
| Sujata Bhowal | Director | 29 Mar 2024 | Current |
| Pradip Kumar Paul | Director | 25 Jun 2013 | Current |
| Tapan Saha | Director | 02 Aug 2012 | Current |
| Nand Kishore Jalan | Director | 02 Aug 2012 | Current |
| Alok Kumar Paul | Director | 02 Aug 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Jul 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kanchanjanga Medipharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.38% increase. The company also saw a slight improvement in profitability, with a 9.62% increase in profit. The company's net worth moved up by a moderate rise of 1.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Kanchanjanga Medipharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Kanchanjanga Medipharma has a workforce of 55 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kanchanjanga Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanchanjanga Medipharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kanchanjanga Medipharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Kanchanjanga Medipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was documented.
Progress on Sujata Bhowal was appointed as a Director was appointed as a Director on 29 Mar 2024 & has been associated with this company since 1 year 8 months . was documented.
The activity Dilip Kumar Saha was appointed as a Director was appointed as a Director on 25 Jun 2013 & has been associated with this company since 12 years 5 months . was completed.
Progress on Pradip Kumar Paul was appointed as a Director was appointed as a Director on 25 Jun 2013 & has been associated with this company since 12 years 5 months . was documented.
Uttam Saha was appointed as a Director was appointed as a Director on 25 Jun 2013 & has been associated with this company since 12 years 5 months . was recorded as a recent event.
The CIN of Kanchanjanga Medipharma Private Limited is U24233WB2012PTC184337.
Kanchanjanga Medipharma Private Limited is headquartered at Majumder Medi Trade, Kuchery Rd Opp. Siliguri Hospital,, Siliguri, West Bengal, 734001.
Kanchanjanga Medipharma Private Limited was incorporated on 02 August 2012.
The current directors of Kanchanjanga Medipharma Private Limited are
The primary industry of Kanchanjanga Medipharma Private Limited is Trade.
Kanchanjanga Medipharma Private Limited is unlisted.
The authorized capital of Kanchanjanga Medipharma Private Limited is ₹1.01 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Kanchanjanga Medipharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX